In 2021, the FDA announced that they had approved Wegovy, a GLP-1 receptor agonist, as a treatment for chronic weight management. Since then, it feels like every pharmaceutical company has jumped at any opportunity to push their own GLP-1 drug for weight loss or weight management. In turn, use of these medications has skyrocketed. Recent reports suggest that as of 2022, 12% of adults in the United States have taken a GLP-1 agonist for weight loss at some point.
These medications are widely viewed as a win for people struggling with weight loss. However, many are also concerned about their long-term physical and mental effects, particularly for people with eating disorders.
To properly discuss these concerns, it’s important to first understand how GLP-1 drugs actually work.
Vaccines: No Risk, No Reward
Vaccines are tools of modern medicine used in keeping us safe and healthy from the spread of disease. The science of vaccination has come a long way in the last 200 years since the first vaccine, the smallpox vaccine, was developed in 1796. As science has developed, so too has the role of the public in deciding whether or not to get vaccinated against preventable diseases. This includes you, too! The amount of information available to us in making these decisions can be overwhelming, especially if we don’t understand the science.
The Curious Case of the CADs Effect: Is Time Travel Actually Real?
We’ve all heard of cause and effect, but what if our universe doesn’t actually follow this principle? That’s the question behind a recent physics study conducted by Dr. Julia Mossbridge at the Mossbridge Institute, who spent a year recording how tiny particles of light (photons) behave inside a dark, sealed box. Her goal was to test something that could be the plot of a science fiction movie: could information about the future somehow show up in experiments done in the present? The phenomenon she studied is called the “causally ambiguous duration sorting effect” or CADS for short. In simpler terms, it’s a hint that the world around us may sometimes blur the line between “before” and “after.”
C2ST Supporters
Alan Schriesheim & Kay Torshen
John A. Cable Foundation
Arch Investors Ltd
Alan Schriesheim & Kay Torshen
John A. Cable Foundation
Arch Investors Ltd
